HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael B Sawyer Selected Research

Uridine

10/2021Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.
4/2016A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.
1/2015Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy?
1/2014Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity.
12/2009UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael B Sawyer Research Topics

Disease

39Neoplasms (Cancer)
03/2022 - 10/2003
10Colorectal Neoplasms (Colorectal Cancer)
03/2021 - 01/2006
7Breast Neoplasms (Breast Cancer)
10/2021 - 05/2008
6Colonic Neoplasms (Colon Cancer)
03/2021 - 01/2006
6Sarcopenia
09/2018 - 04/2009
5Body Weight (Weight, Body)
01/2021 - 08/2009
5Fibrosis (Cirrhosis)
01/2018 - 12/2009
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 12/2013
4Diarrhea
03/2022 - 12/2007
4Fatigue
03/2021 - 02/2010
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020 - 01/2015
4Stomach Neoplasms (Stomach Cancer)
09/2014 - 12/2009
3Adenocarcinoma
10/2022 - 10/2014
3Melanoma (Melanoma, Malignant)
10/2021 - 01/2020
3Ovarian Neoplasms (Ovarian Cancer)
02/2016 - 12/2010
3Renal Cell Carcinoma (Grawitz Tumor)
06/2015 - 02/2010
2Gastroesophageal Reflux (GERD)
03/2022 - 01/2015
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2010
2Paraganglioma (Paragangliomas)
03/2016 - 02/2016
2Pheochromocytoma
03/2016 - 02/2016
2Obesity
02/2016 - 07/2008
2Rectal Neoplasms (Rectal Cancer)
10/2014 - 02/2010
2Ascites
06/2014 - 02/2012
2End Stage Liver Disease
06/2014 - 02/2012
2Cachexia
10/2013 - 01/2011
2Liver Diseases (Liver Disease)
02/2012 - 12/2009
1Neutropenia
10/2022
1Fever (Fevers)
03/2022
1Atrophy
03/2022
1Leukopenia
10/2021
1Paresthesia (Dysesthesia)
03/2021

Drug/Important Bio-Agent (IBA)

9Fluorouracil (Carac)FDA LinkGeneric
03/2021 - 06/2007
8Pharmaceutical PreparationsIBA
03/2022 - 01/2006
8Capecitabine (Xeloda)FDA Link
03/2021 - 04/2009
8NucleosidesIBA
01/2018 - 10/2003
7GemcitabineFDA Link
10/2022 - 05/2008
7Irinotecan (Camptosar)FDA LinkGeneric
01/2014 - 12/2007
6Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2021 - 01/2006
5Proton Pump InhibitorsIBA
03/2022 - 01/2016
5UridineIBA
10/2021 - 12/2009
4EnzymesIBA
03/2022 - 12/2007
4Leucovorin (Folinic Acid)FDA Link
03/2021 - 06/2007
4Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2006
4Tyrosine Kinase InhibitorsIBA
09/2019 - 10/2014
4Sorafenib (BAY 43-9006)FDA Link
09/2019 - 12/2009
4Sunitinib (Sutent)FDA Link
01/2018 - 01/2015
4Glutamine (L-Glutamine)FDA Link
01/2011 - 12/2007
3130-nm albumin-bound paclitaxelIBA
10/2022 - 01/2021
3Epirubicin (Ellence)FDA LinkGeneric
10/2021 - 01/2011
3Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
10/2021 - 12/2009
3Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2018
3Carboplatin (JM8)FDA LinkGeneric
01/2017 - 12/2009
3CreatinineIBA
07/2015 - 02/2012
3BilirubinIBA
06/2014 - 12/2009
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
08/2009 - 12/2007
2NivolumabIBA
01/2021 - 10/2018
2Fatty Acids (Saturated Fatty Acids)IBA
12/2020 - 09/2014
2PlatinumIBA
12/2020 - 01/2006
2IpilimumabIBA
01/2020 - 10/2018
2Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 12/2012
2Lapatinib (GW572016)FDA Link
06/2017 - 01/2016
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2015 - 01/2014
2Amino AcidsFDA Link
09/2014 - 04/2008
2CarbohydratesIBA
09/2014 - 01/2014
2Estrogens (Estrogen)FDA Link
01/2014 - 05/2008
2SodiumIBA
11/2013 - 02/2012
2Monoclonal AntibodiesIBA
07/2013 - 12/2009
2Antineoplastic Agents (Antineoplastics)IBA
05/2011 - 02/2010
2Trastuzumab (Herceptin)FDA Link
03/2011 - 12/2009
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2011 - 12/2008
2PrebioticsIBA
01/2011 - 12/2007
2AnthracyclinesIBA
12/2009 - 04/2009
2fludarabineIBA
06/2009 - 05/2008
2CladribineFDA LinkGeneric
06/2009 - 05/2008
2GlucuronidaseIBA
04/2008 - 12/2007
2Paclitaxel (Taxol)FDA LinkGeneric
07/2007 - 03/2007
2Hemoglobins (Hemoglobin)IBA
01/2006 - 05/2003
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
10/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2022
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
03/2022
1Anti-Bacterial Agents (Antibiotics)IBA
03/2022
1Amoxicillin (Wymox)FDA LinkGeneric
03/2022
1MagnesiumIBA
03/2022
1Ciprofloxacin (Cipro)FDA LinkGeneric
03/2022
1Pantoprazole (Protonix)FDA LinkGeneric
03/2022
1TabletsIBA
03/2022
1FluoroquinolonesIBA
03/2022
1Bicarbonates (Hydrogen Carbonate)IBA
03/2022
1Pemetrexed (MTA)FDA Link
03/2021
1raltitrexed (D 1694)IBA
03/2021

Therapy/Procedure

25Drug Therapy (Chemotherapy)
03/2022 - 10/2003
14Therapeutics
03/2022 - 12/2007
5Liver Transplantation
01/2018 - 01/2010
2Immunotherapy
10/2021 - 01/2021
2Neoadjuvant Therapy
03/2016 - 01/2010
2Length of Stay
02/2016 - 06/2014
1Palliative Care (Palliative Therapy)
03/2022
1Enzyme Replacement Therapy
03/2022
1Radiotherapy
03/2022